349 related articles for article (PubMed ID: 7532549)
1. Noncytotoxic human CD4+ T-cell clones presenting and simultaneously responding to an antigen die of apoptosis.
Bettens F; Frei E; Frutig K; Mauri D; Pichler WJ; Wyss-Coray T
Cell Immunol; 1995 Mar; 161(1):72-8. PubMed ID: 7532549
[TBL] [Abstract][Full Text] [Related]
2. Peptide-induced T cell clones: specificity, MHC restriction, proliferation and cytokine pattern as a function of different stimulations.
Pichler WJ; Brander C; Mauri D; Frutig K; Wyss-Coray T
Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1994; (87):141-53; discussion 153-4. PubMed ID: 7873053
[TBL] [Abstract][Full Text] [Related]
3. Discrimination of human CD4 T cell clones based on their reactivity with antigen-presenting T cells.
Wyss-Coray T; Brander C; Frutig K; Pichler WJ
Eur J Immunol; 1992 Sep; 22(9):2295-302. PubMed ID: 1381313
[TBL] [Abstract][Full Text] [Related]
4. Cognate MHC-TCR interaction leads to apoptosis of antigen-presenting cells.
Setterblad N; Blancheteau V; Delaguillaumie A; Michel F; Bécart S; Lombardi G; Acuto O; Charron D; Mooney N
J Leukoc Biol; 2004 Jun; 75(6):1036-44. PubMed ID: 14982950
[TBL] [Abstract][Full Text] [Related]
5. CD40-stimulated B lymphocytes pulsed with tumor antigens are effective antigen-presenting cells that can generate specific T cells.
Lapointe R; Bellemare-Pelletier A; Housseau F; Thibodeau J; Hwu P
Cancer Res; 2003 Jun; 63(11):2836-43. PubMed ID: 12782589
[TBL] [Abstract][Full Text] [Related]
6. Antigen-presenting human T cells and antigen-presenting B cells induce a similar cytokine profile in specific T cell clones.
Wyss-Coray T; Gallati H; Pracht I; Limat A; Mauri D; Frutig K; Pichler WJ
Eur J Immunol; 1993 Dec; 23(12):3350-7. PubMed ID: 7504995
[TBL] [Abstract][Full Text] [Related]
7. B lymphocytes acquire and present intracellular antigens that have relocated to the surface of apoptotic target cells.
Ciechomska M; Lennard TW; Kirby JA; Knight AM
Eur J Immunol; 2011 Jul; 41(7):1850-61. PubMed ID: 21590765
[TBL] [Abstract][Full Text] [Related]
8. Function and regulation of MHC class II molecules in T-lymphocytes: of mice and men.
Holling TM; Schooten E; van Den Elsen PJ
Hum Immunol; 2004 Apr; 65(4):282-90. PubMed ID: 15120183
[TBL] [Abstract][Full Text] [Related]
9. Requirement for efficient interactions between CD4 and MHC class II molecules for survival of resting CD4+ T lymphocytes in vivo and for activation-induced cell death.
Maroto R; Shen X; König R
J Immunol; 1999 May; 162(10):5973-80. PubMed ID: 10229835
[TBL] [Abstract][Full Text] [Related]
10. MHC class II-expressing hepatocytes function as antigen-presenting cells and activate specific CD4 T lymphocyutes.
Herkel J; Jagemann B; Wiegard C; Lazaro JF; Lueth S; Kanzler S; Blessing M; Schmitt E; Lohse AW
Hepatology; 2003 May; 37(5):1079-85. PubMed ID: 12717388
[TBL] [Abstract][Full Text] [Related]
11. Differential responses of invariant V alpha 24J alpha Q T cells and MHC class II-restricted CD4+ T cells to dexamethasone.
Milner JD; Kent SC; Ashley TA; Wilson SB; Strominger JL; Hafler DA
J Immunol; 1999 Sep; 163(5):2522-9. PubMed ID: 10452989
[TBL] [Abstract][Full Text] [Related]
12. Anergy induction in human CD4+ T-cell clones by stimulation with soluble peptides does not require cell proliferation and is accompanied by elevated IL4 production.
Grunow R; Frutig K; Pichler WJ
Cell Immunol; 1996 Oct; 173(1):79-86. PubMed ID: 8871603
[TBL] [Abstract][Full Text] [Related]
13. Differential susceptibility to monomeric HIV gp120-mediated apoptosis in antigen-activated CD4+ T cell populations.
Tuosto L; Gilardini Montani MS; Lorenzetti S; Cundari E; Moretti S; Lombardi G; Piccolella E
Eur J Immunol; 1995 Oct; 25(10):2907-16. PubMed ID: 7589091
[TBL] [Abstract][Full Text] [Related]
14. The immunogenic potential of human fetal retinal pigment epithelium and its relation to transplantation.
Rezai KA; Semnani RT; Patel SC; Ernest JT; van Seventer GA
Invest Ophthalmol Vis Sci; 1997 Nov; 38(12):2662-71. PubMed ID: 9375586
[TBL] [Abstract][Full Text] [Related]
15. Antigen targeting to antigen-presenting cells enhances presentation to class II-restricted T lymphocytes.
Scardino A; Paroli M; De Petrillo G; Michel ML; Barnaba V
Immunology; 1994 Jan; 81(1):167-70. PubMed ID: 7907575
[TBL] [Abstract][Full Text] [Related]
16. Antigen presentation of mycobacterial peptides to human T cell clones can be immunomodulated by adding an MHC-specific inhibitor.
Méndez-Samperio P
Cell Immunol; 1993 Apr; 148(1):1-9. PubMed ID: 8495481
[TBL] [Abstract][Full Text] [Related]
17. Concerted antigen presentation by dendritic cells and B cells is necessary for optimal CD4 T-cell immunity in vivo.
Kleindienst P; Brocker T
Immunology; 2005 Aug; 115(4):556-64. PubMed ID: 16011524
[TBL] [Abstract][Full Text] [Related]
18. T-cell presentation of antigen requires cell-to-cell contact for proliferation and anergy induction. Differential MHC requirements for superantigen and autoantigen.
LaSalle JM; Toneguzzo F; Saadeh M; Golan DE; Taber R; Hafler DA
J Immunol; 1993 Jul; 151(2):649-57. PubMed ID: 7687620
[TBL] [Abstract][Full Text] [Related]
19. Rafting MHC-II domains in the APC (presynaptic) plasma membrane and the thresholds for T-cell activation and immunological synapse formation.
Gombos I; Detre C; Vámosi G; Matkó J
Immunol Lett; 2004 Mar; 92(1-2):117-24. PubMed ID: 15081535
[TBL] [Abstract][Full Text] [Related]
20. MHC class II-mediated antigen presentation by alloreactive rat CD4+ T cells does not induce regulatory properties.
Otto C; Heeg A; Kottenmeier S; Tiurbe GC; Thiede A; Ulrichs K
Transplant Proc; 2006 Apr; 38(3):755-6. PubMed ID: 16647463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
